Pathogenesis of Parkinson’s Disease
Neurologic Clinics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
289, P. 138633 - 138633
Published: Dec. 13, 2024
Language: Английский
Vagus nerve stimulation and gut microbiota interactions: a novel therapeutic avenue for neuropsychiatric disorders
Navid Faraji,
No information about this author
Bahareh Payami,
No information about this author
Negar Ebadpour
No information about this author
et al.
Neuroscience & Biobehavioral Reviews,
Journal Year:
2024,
Volume and Issue:
unknown, P. 105990 - 105990
Published: Dec. 1, 2024
The
rising
prevalence
of
treatment-resistant
neuropsychiatric
disorders
underscores
the
need
for
innovative
and
effective
treatment
strategies.
gut
microbiota
(GM)
plays
a
pivotal
role
in
progression
these
diseases,
influencing
brain
mental
health
through
gut-brain
axis
(GBA).
vagus
nerve
significant
GBA,
making
it
key
area
focus
potential
novel
therapeutic
interventions.
Vagus
stimulation
(VNS)
was
introduced
approved
as
refractory
forms
some
neuropsychological
disorders,
such
depression
epilepsy.
Considering
its
impact
on
several
regions
that
play
vital
part
mood,
motivation,
affection,
cognitive
function,
VNS
has
shown
treating
variety
disorders.
Harnessing
to
target
bidirectional
communication
pathways
linking
GM
VN
could
present
an
exciting
approach
Imbalances
GM,
dysbiosis,
can
impair
between
brain,
contributing
development
shows
modulating
interconnected
systems,
helping
restore
balance.
Interestingly,
composition
may
also
influence
effectiveness
VNS,
modify
brain's
response
this
approach.
This
study
provides
comprehensive
analysis
relatively
unexplored
but
noteworthy
interaction
In
addition,
we
discussed
mechanisms,
potential,
clinical
implications
GBA
across
Language: Английский
The Neuroprotective Effects of Agmatine on Parkinson’s Disease: Focus on Oxidative Stress, Inflammation and Molecular Mechanisms
Inflammation,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 3, 2024
Language: Английский
Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(17), P. 2946 - 2946
Published: Sept. 2, 2024
Parkinson’s
disease
is
associated
with
gastrointestinal
(GI)
dysfunction,
including
constipation
symptoms
and
abnormal
intestinal
permeability
inflammation.
A
Mediterranean
diet
(MediDiet)
may
aid
in
management.
This
parallel,
randomized,
controlled
trial
people
(PwP)
compared
a
MediDiet
against
standard
of
care
on
change
symptoms,
dietary
intake,
fecal
zonulin
calprotectin
concentrations
as
markers
inflammation,
respectively.
Participants
were
randomized
to
either
for
(control;
n
=
17,
65.1
±
2.2
years)
or
plus
(n
19,
68.8
1.4
8
weeks.
Constipation
scores
decreased
both
interventions
(p
<
0.01),
but
changes
from
baseline
not
different
between
groups
(MediDiet,
−0.5
[−1.0,
0];
control,
−0.8
0.2];
median
[25th,
75th];
p
0.60).
The
group
had
higher
intake
fiber
at
week
4
than
the
control
(13.1
0.7
g/1000
kcal
vs.
9.8
kcal;
0.001).
No
differences
observed
0.33);
however,
tended
be
lower
(45.8
15.1
µg/g
93.9
26.8
µg/g;
0.05).
reduced
symptoms;
provided
additional
benefit
increased
less
Language: Английский
Therapeutic potential of green tea catechins on the development of Parkinson’s disease symptoms in a transgenic A53T mouse model
Elizabeth Riegelman,
No information about this author
Kathy S. Xue,
No information about this author
Jia-Sheng Wang
No information about this author
et al.
Nutritional Neuroscience,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 17
Published: Nov. 29, 2024
Objectives:
This
study
aimed
to
evaluate
the
effects
of
green
tea
catechins
on
prevention
Parkinson's
disease
neurobehavioral
symptoms
and
α-synuclein
blood
plasma
concentration
in
a
hemizygous
transgenic
A53T
mouse
model.
Language: Английский
Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research: A Scoping Review and Translational Prospects
Rachid Kacemi,
No information about this author
María G. Campos
No information about this author
Molecules,
Journal Year:
2024,
Volume and Issue:
29(24), P. 5893 - 5893
Published: Dec. 13, 2024
Bee
Pollen
(BP)
has
many
advantageous
properties
relying
on
its
multitargeting
potential,
a
new
tendency
in
managing
challenging
illnesses.
In
cancer
and
neurodegeneration,
the
multiple
effects
of
BP
could
be
unequaled
importance
need
further
investigation.
Although
still
limited,
available
data
interestingly
spotlights
some
floral
sources
with
promising
activities
line
this
Adopting
scoping
review
methodology,
we
have
identified
crucial
bioactivities
that
are
widely
recognized
to
individual
compounds
but
remain
completely
untapped
valuable
bee
cocktail.
A
wide
range
these
been
recently
found
endowed
great
potential
modulating
pivotal
processes
neurodegeneration
pathophysiology.
addition,
ubiquitous
only
isolated,
while
number
studied
BPs
remains
extremely
limited
compared
endless
pool
plant
species
worldwide.
We
also
elucidated
clinical
profits
from
perspectives
impeded
by
hurdles
such
as
bioavailability
phytocompounds,
diversity
lack
phytochemical
standardization
BP,
difficulty
selective
targeting
pathophysiological
mechanisms.
finally
present
interesting
insights
guide
future
research
pave
way
for
urgently
needed
simplified
investigations.
Language: Английский